R e a l - T i m e S o l u t i o n f o r
Ocular Vascular Health
Choroidal Circulation Analyzer
The OculoPULSE is a pioneering device designed specifically to measure choroidal circulation, which constitutes approximately 85% of ocular blood flow. In contrast, most existing devices primarily assess retinal blood flow, which represents only about 10% of total eye circulation. With over 40 years of experience as an ophthalmologist, the developers of OculoPULSE bring invaluable expertise to the field of ocular health.
About OculoPULSE
OculoPULSE is a premarket medical device company specializing in a tonometer that accurately measures intraocular pressure (IOP), mean ocular perfusion pressure (OPP), and pulsatile ocular blood flow (POBF). By facilitating early detection of POBF abnormalities, OculoPULSE enables clinicians to prescribe appropriate therapies for various ocular conditions linked to abnormal blood circulation.
These conditions, which include glaucoma, age-related macular degeneration (AMD), and diabetic retinopathy (DR), are projected to affect ONE in FOUR Americans, leading to functional blindness by the end of life. This is similar in economically developed countries globally.
Regularly measuring and monitoring POBF can help delay the progression of these blinding conditions. The introduction of OculoPULSE represents a significant shift in how we approach the management of ocular health.
These conditions, which include glaucoma, age-related macular degeneration (AMD), and diabetic retinopathy (DR), are projected to affect ONE in FOUR Americans, leading to functional blindness by the end of life. This is similar in economically developed countries globally.
Regularly measuring and monitoring POBF can help delay the progression of these blinding conditions. The introduction of OculoPULSE represents a significant shift in how we approach the management of ocular health.
Global Market Overview:
Glaucoma, Age-Related Macular Degeneration, and Diabetic Retinopathy
Value of Global Market in US$ Billions
2021 = $24.3 Billion
2030 = $41.0 Billion
Understanding this market is crucial for addressing the growing concern of visual impairment among the American population.
Eye Circulation Measurement
Image-Based Technologies (OCT)
- Type: Retinal Circulation
- Percentage of Ocular Blood Flow: 10%
- Characteristics: Anatomic and Static
- Coverage: Posterior Pole Circulation
- Price: ~$100K
- Disease Stage: Late
Color Doppler Imaging
- Type: Retrobulbar Circulation
- Percentage of Ocular Blood Flow: 50%
- Characteristics: Functional
- Coverage: Arterial Feeder Circulation
- Price: ~$100K per device
- Disease Stage: Early and Late
Choroidal Circulation Analyzer
- Type: Choroidal Circulation
- Percentage of Ocular Blood Flow: 85-90%
- Characteristics: Functional & Real-Time
- Coverage: Global & Perfusion Pressure
- Price: ~$10-15K per device
- Disease Stage: Early and Late
Disclaimer
The OculoPULSE product has not been approved by the FDA. This presentation contains forward-looking statements intended for investor use only. Nothing herein should be construed as a solicitation or offer to buy or sell securities.